Compare Stocks → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:BBHNYSEARCA:IPO Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBHVanEck Biotech ETF$154.77-1.6%$162.38$142.51▼$171.04$417.88M0.859,120 shs53,720 shsIPORenaissance IPO ETF$37.46-0.5%$39.48$27.09▼$42.40$176.06M1.6461,851 shs22,658 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBHVanEck Biotech ETF+0.11%+2.83%-4.78%-5.84%-1.94%IPORenaissance IPO ETF-1.05%+1.35%-9.99%+8.97%+39.08%AI finds its first serious application (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industryMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBBHVanEck Biotech ETFN/AN/AN/AN/AN/AN/AN/AN/AIPORenaissance IPO ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBHVanEck Biotech ETF0.00N/A$190.0122.77% UpsideIPORenaissance IPO ETF0.00N/A$42.4013.18% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBHVanEck Biotech ETFN/AN/AN/AN/AN/AN/AIPORenaissance IPO ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBHVanEck Biotech ETFN/AN/A0.00∞N/AN/AN/AN/AN/AIPORenaissance IPO ETFN/AN/A42.29∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBBHVanEck Biotech ETF$0.710.46%N/AN/AN/AIPORenaissance IPO ETFN/AN/AN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBHVanEck Biotech ETF32.05%IPORenaissance IPO ETFN/AInsider OwnershipCompanyInsider OwnershipBBHVanEck Biotech ETFN/AIPORenaissance IPO ETFN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBBHVanEck Biotech ETFN/A2.70 millionN/AOptionableIPORenaissance IPO ETFN/A4.70 millionN/ANot OptionableBRWM, IPO, HUB, BBH, and LWI HeadlinesSourceHeadlineTravel firm Viking aims for up to $10.8 billion valuation in US IPOmsn.com - April 22 at 12:35 PMIPO Roundup: Rubrik, Marex Group, Loar Holdings, and moremsn.com - April 22 at 12:35 PMCruise operator Viking sets IPO terms, to valued at up to $10.7 billionmsn.com - April 22 at 7:34 AMIbotta IPO jumps as investors continue to buy into AI hype (update)seekingalpha.com - April 19 at 10:41 AMWall Street Investment Banking Gains Momentum: ETFs in Focuszacks.com - April 19 at 9:01 AMIbotta’s IPO prices above range at $88 a share to raise $577 millionmsn.com - April 18 at 6:11 PMIsraeli smart glass maker Gauzy files for IPO with plan to list on Nasdaqmsn.com - April 16 at 2:24 PMMicrosoft-allied Rubrik could be valued at more than $5 billion after IPOmsn.com - April 16 at 2:24 PMWhat could spur an IPO pickup in the second half of the yearfinance.yahoo.com - April 15 at 3:54 PMIPO Roundup: Ibotta, Centuri Holdings, and moremsn.com - April 15 at 10:53 AMHealthcare, tech are 'major players' in IPO momentumfinance.yahoo.com - April 9 at 4:02 PMThis Fintech Was Just Valued at $65 Billion. Could It Become 1 of 2024's Largest IPOs?msn.com - April 7 at 10:26 AMFranklin Templeton: Ordinals Driving 'Renaissance' in Bitcoin Innovationbitcoinmagazine.com - April 4 at 8:02 AMUL Solutions launches IPO with plans for valuation of up to $5.8 billionmarketwatch.com - April 2 at 8:15 AMThe path forward for IPOs as Wall Street warms up to fresh listingsfinance.yahoo.com - April 1 at 2:23 PMBayer-backed Boundless Bio sees stock fall 8% after $100M IPOmsn.com - March 28 at 8:29 PMIPOs Are Back. What They Say About a Stock Market Bubble.msn.com - March 27 at 8:21 AMTime for IPO ETFs?zacks.com - March 25 at 3:01 PMReddit's Successful IPO Puts These ETFs in Focuszacks.com - March 25 at 8:21 AMReddit Gets Its IPO Priced: $34 Per Sharemsn.com - March 21 at 5:16 PMAstera Labs’ IPO pops 54%, showing that investor demand for tech with an AI-twist is highyahoo.com - March 20 at 6:45 PMAll eyes may be on the Reddit IPO, but Astera Labs could rocket with its IPOmsn.com - March 20 at 6:45 PMAstera Labs IPO will reveal how much investors want in on AItechcrunch.com - March 19 at 6:46 PMIPO240419P00042000 (IPO240419P00042000) Interactive Stock Chart - Yahoo Financefinance.yahoo.com - March 18 at 9:01 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioStock market today: Wall Street falls on double dose of disappointing economic data, as Meta sinksApril 25, 2024 2:14 AMView Stock market today: Wall Street falls on double dose of disappointing economic data, as Meta sinksFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains Imminent5 Stocks in the Current Bull Market with Upside to ComeApril 5, 2024 10:14 AMView 5 Stocks in the Current Bull Market with Upside to ComeWhat is the Nasdaq? Complete Overview with HistoryApril 16, 2024 8:00 AMView What is the Nasdaq? Complete Overview with HistoryAll Headlines Company DescriptionsVanEck Biotech ETFNASDAQ:BBHThe BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.Renaissance IPO ETFNYSEARCA:IPOThe Renaissance IPO ETF (IPO) is an exchange-traded fund that is based on the FTSE Renaissance IPO index. The fund tracks a market cap-weighted index of recent US-listed IPOs. The fund acquires issues within 90 days or sooner after IPO and sells after 3 years. IPO was launched on Oct 14, 2013 and is managed by Renaissance. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
